ABSTRACT
Background: Inflammation can be classified as either acute or chronic. NSAIDs are the most commonly prescribed drugs worldwide, and mostly have adverse effects. Lercanidipine a CCB of (DHPs) blocks the mediators of inflammation and has additional anti-inflammatory potential. Tanacetum parthenium (Feverfew) extracts have also shown its anti-inflammatory effects in experimental studies. It was decided to study anti-inflammatory effects of Lercanidipine and Tanacetum parthenium which was compared with Indomethacin. The present study was aimed to evaluate and compare the anti-inflammatory effect of lercanidipine and Tanacetum parthenium with Indomethacin in rats.Methods: The study was conducted in the department of Pharmacology UPUMS, Saifai after getting approval from IAEC.A total of 24 animals divided into 4 groups of six (n=6) animals each group were used, and the anti-inflammatory effects of both drugs were evaluated by Carrageenan-induced Paw Edema Model by digital Plethysmometer in rats, drug administration was with the same frequency.Results: The result of the present study had shown that lercanidipine produced anti-inflammatory effect compared to Indomethacin, while its efficacy in reducing paw edema was better at 1st hour, 48 and 72 hours while at 2nd hour and 3rd hour Indomethacin had better efficacy. Tanacetum parthenium also decreased paw edema at 2nd, 3rd, 48 and 72 hour while at 1st hour no effect was seen. However, at 72 hours, shown good efficacy compared to lercanidipine and Indomethacin.Conclusions: Lercanidipine could be a promising anti-inflammatory drug in reducing the inflammation and edema. However, herbal drug (Tanacetum parthenium) has shown anti- inflammatory efficacy when compared with Indomethacin. Both drugs were found safe during our study.
ABSTRACT
Los procesos inflamatorios no controlados producen daño celular donde los radicales libres están presentes y representan un peligro para la vida del paciente, en este contexto la búsqueda de moléculas de origen vegetal son incesantes por su aceptación cultural, una mejor compatibilidad con el cuerpo humano y menos efectos secundarios. El objetivo fue determinar la actividad antioxidante y antiinflamatoria del extracto hidroalcohólico de las flores de Tanacetum parthenium L. Sch. Bip. "santa maria", empleando la técnica in vitro del DPPH y el modelo in vivo de edema plantar inducida por carragenina en ratas Wistar. Se llevó a cabo en los laboratorios de la Escuela de Farmacia y Bioquímica de la Universidad Nacional de San Cristóbal de Huamanga, Ayacucho, Perú. La muestra fue recolectada en la ciudad de Huancayo, región Junin. Se ensayó concentraciones de 1, 2 y 3% en ungüentos base como vehículo semisólido usando el estándar de referencia diclofenaco gel 1%. El extracto hidroalcohólico contiene fenoles y taninos, flavonoides, faetonas y/o cumarinas, triterpenos y/o esteroides y aminoácidos. La concentración de extracto hidroalcohólico de las flores de Tanacetum parthenium L. Sch. Bip. "santa maria" con mayor actividad antiinflamatoria fue al 3%, con un porcentaje de desinflamación del84.6% {porcentaje de inflamación de 15.4%) y con un ABC de 6,214 mllt2. La concentración de extracto hidroalcohólico de las flores de Tanacetum parthenium L. Sch. Bip. "santa maria" con mayor actividad antioxidante fue a 100 ¡Jg/ml, con un porcentaje de 63,9%. Se concluye que el extracto hidroalcohólico de las flores de Tanacetum parthenium L. Sch. Bip. "santa maría" tiene poca actividad antioxidante in vitro pero buena actividad antiinflamatoria in vivo estadísticamente similar al diclofenaco por lo que constituyen una fuente potencial para el tratamiento antiinflamatorio tópico.
Subject(s)
Animals , Rats , Tanacetum parthenium , Anti-Inflammatory Agents , Antioxidants , Peru , In Vitro Techniques , Hydroalcoholic Solution , Models, AnimalABSTRACT
Tanacetum parthenium (feverfew) is an herb that is commercialized worldwide as a therapeutic treatment for migraine. Its pharmacological effect is mainly due to the presence of the sesquiterpene lactone parthenolide as well as of flavonoids. So far, there are no studies on standardization of pre-formulations or phytomedicines containing this herb. The present study aimed at developing a pre-formulation using a standardized spray-dried extract of feverfew and further designing and standardizing enteric coated tablets. In this work, the spray-dried extract of feverfew was evaluated for its parthenolide, santin and total flavonoid content, parthenolide solubility, particle size, tapped density, hygroscopicity, angle of repose and moisture content. Tablets containing the spray-dried extract were tested for their average weight, friability, hardness, and disintegration time. The total flavonoid and parthenolide contents in the spray-dried extract were 1.31 percent and 0.76 percent w/w, respectively. The spray-dried extract presented consistent pharmacotechnical properties and allowed its tableting by direct compression. Tablet properties were in accordance with the proposed specifications. The procedures described herein can be used to prepare and evaluate pre-formulations of feverfew with adequate properties for the development of a high-quality phytomedicine.
Tanacetum parthenium (tanaceto) é uma planta medicinal comercializada no mundo todo para tratamento de enxaqueca. Seu efeito farmacológico é creditado principalmente à lactona sesquiterpênica partenolídeo e flavonóides. Até o momento não existem estudos sobre a padronização de pré-formulações ou o desenvolvimento de fitoterápicos com tanaceto. Logo, o objetivo deste trabalho foi obter comprimidos de revestimento entérico a partir de extrato seco e padronizado de tanaceto. Neste trabalho, o extrato seco do tanaceto obtido pelo método de spray drying foi avaliado quanto ao teor de partenolídeo, presença da santina, teor de flavonóides totais, solubilidade do partenolídeo, tamanho de partícula, ângulo de repouso, densidade, análise higroscópica e teor de umidade. A partir do extrato seco obtiveram-se comprimidos que foram revestidos em leito de jorro. Os comprimidos revestidos foram avaliados com relação ao peso médio, friabilidade, dureza e desintegração. O teor de flavonóides totais e de partenolídeo no extrato seco foram 1,31 por cento e 0,76 por cento (p/p), respectivamente. O extrato seco apresentou características farmacotécnicas satisfatórias permitindo a obtenção de comprimidos pelo método de compressão direta. As propriedades dos comprimidos revestidos estão de acordo com as especificações da literatura. Os procedimentos utilizados nesse trabalho podem ser utilizados para obter extrato seco e fitoterápicos de T. parthenium com alto padrão de qualidade.
Subject(s)
Artemisia , Tablets, Enteric-Coated/pharmacology , Plant Extracts , Tanacetum parthenium , Flavonoids , Lactones/therapeutic use , Phytotherapeutic Drugs , SesquiterpenesABSTRACT
Neste trabalho, é apresentada uma proposta para o controle de qualidade físico e químico do pó de T. parthenium (tanaceto) e do seu extrato hidroalcoólico obtido por percolação. A lactona sesquiterpênica partenolídeo, o principal componente ativo da espécie, foi quantificada por CLAE e seu teor foi de 0,49 por cento no pó e 1,06 por cento no extrato. O teor de flavonóides totais foi determinado por espectroscopia no UV e foi de 0,54 por cento no pó e 1,05 por cento no extrato hidroalcoólico. A santina, principal flavonóide da espécie, foi isolada e posteriormente identificada no extrato por CLAE. Uma vez que o partenolídeo também pode ser encontrado em outras espécies de Asteraceae, a análise da santina é importante para certificar a autenticidade do material vegetal. Os resultados obtidos neste trabalho confirmam a autenticidade do material e a eficiência do processo extrativo.
In this study, we present a proposal for the physical and chemical quality control of the powder of the species T. parthenium (feverfew) and its hydroalcoholic extract obtained by percolation. The sesquiterpene lactone parthenolide, the main active compound of this plant, was quantified by HPLC and its content was found to be 0.49 percent in the powder and 1.06 percent in the extract. The total content of flavonoids, determined by UV spectroscopy, was found to be 0.54 percent in the powder and 1.05 percent in the hydroalcoholic extract. Santin, the main flavonoid of this species, was isolated and further identified in the extract by HPLC. Since parthenolide can also be found in other Asteraceae species, the analysis of santin is important to certify the authenticity of the plant material. The results confirmed the authenticity of the plant material and the efficiency of the extraction procedure.